NDC 36987-2585
Salt Cedar
Salt Cedar
Salt Cedar is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Nelco Laboratories, Inc.. The primary component is Tamarix Gallica Pollen.
| Product ID | 36987-2585_2a72f629-5585-48e0-bd3f-7804035e57fb |
| NDC | 36987-2585 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Salt Cedar |
| Generic Name | Salt Cedar |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRADERMAL; SUBCUTANEOUS |
| Marketing Start Date | 1972-08-29 |
| Marketing Category | BLA / BLA |
| Application Number | BLA102192 |
| Labeler Name | Nelco Laboratories, Inc. |
| Substance Name | TAMARIX GALLICA POLLEN |
| Active Ingredient Strength | 40000 [PNU]/mL |
| Pharm Classes | Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
Packaging
NDC 36987-2585-4
50 mL in 1 VIAL, MULTI-DOSE (36987-2585-4)
| Marketing Start Date | 1972-08-29 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 36987-2585-2 [36987258502]
Salt Cedar INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
NDC 36987-2585-4 [36987258504]
Salt Cedar INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
NDC 36987-2585-3 [36987258503]
Salt Cedar INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
NDC 36987-2585-1 [36987258501]
Salt Cedar INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| TAMARIX GALLICA POLLEN | 40000 [PNU]/mL |
OpenFDA Data
Pharmacological Class
- Non-Standardized Pollen Allergenic Extract [EPC]
- Increased Histamine Release [PE]
- Cell-mediated Immunity [PE]
- Increased IgG Production [PE]
- Pollen [CS]
- Allergens [CS]
- Non-Standardized Pollen Allergenic Extract [EPC]
- Increased Histamine Release [PE]
- Cell-mediated Immunity [PE]
- Increased IgG Production [PE]
- Pollen [CS]
- Allergens [CS]
NDC Crossover Matching brand name "Salt Cedar" or generic name "Salt Cedar"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 36987-2581 | Salt Cedar | Salt Cedar |
| 36987-2582 | Salt Cedar | Salt Cedar |
| 36987-2583 | Salt Cedar | Salt Cedar |
| 36987-2584 | Salt Cedar | Salt Cedar |
| 36987-2585 | Salt Cedar | Salt Cedar |
| 36987-2586 | Salt Cedar | Salt Cedar |
| 36987-2587 | Salt Cedar | Salt Cedar |
| 36987-2588 | Salt Cedar | Salt Cedar |
| 49288-0133 | Salt Cedar | Salt Cedar |
Trademark Results [Salt Cedar]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 SALT CEDAR 78418513 not registered Dead/Abandoned |
Moses, Gary 2004-05-13 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.